ArticleJournal of medicinal chemistry1998

Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.

Y C Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.